Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

147330 Press Releases
DateTitleCompany
08 Dec 16 Gilead Submits New Drug Application to U.S. Food and Drug Administration for the Investigational Single Tablet Regimen Sofosbuvir/Velpatasvir/Voxilaprevir Gilead Sciences, Inc.,
Published by
Business Wire
08 Dec 16 Matinas BioPharma Receives Contract Award from Cystic Fibrosis Foundation Therapeutics to Study MAT2501 for the Treatment of NTM-Infection in Pre-Clinical Models of CF Published by
GlobeNewswire
08 Dec 16 Horizon Pharma plc Announces Topline Results from Phase 3 Study of  ACTIMMUNE® (interferon gamma-1b) in Friedreich's Ataxia Published by
GlobeNewswire
08 Dec 16 Oxford Immunotec Announces New England Journal of Medicine Publication on Clinical Trial Results of Serological and Nucleic Acid Tests for Babesia in Blood Screening Published by
GlobeNewswire
08 Dec 16 Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Novel Treatment Paradigm for Pompe Disease Published by
GlobeNewswire
08 Dec 16 Zynerba Pharmaceuticals to Host Clinical Research Day on December 15, 2016 to Discuss the Role of ZYN002 CBD Gel in Multiple Diseases Published by
GlobeNewswire
08 Dec 16 Tonix Pharmaceuticals Presented New Clinical Results from Sub-Group Analysis of Phase 2 AtEase Study in Military-Related Posttraumatic Stress Disorder (PTSD) Published by
GlobeNewswire
08 Dec 16 Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT® Published by
GlobeNewswire
08 Dec 16 Anavex Life Sciences Announces 12-Month Data of ANAVEX 2-73 in a Phase 2a Study in Mild-to-Moderate Alzheimer’s Disease Patients Published by
GlobeNewswire
08 Dec 16 PCI Biotech and eTheRNA immunotherapies initiate research collaboration PCI Biotech Holding,
Published by
GlobeNewswire
08 Dec 16 PCI Biotech: Rights issue approved by the extraordinary general meeting PCI Biotech Holding,
Published by
GlobeNewswire
08 Dec 16 Greg Nash joins Ovia Health as Executive Vice President Ovia Health,
Published by
PR Newswire
08 Dec 16 Integrated care pavilion opens at Stamford Health, expands access to specialized services Stamford Health,
Published by
PR Newswire
08 Dec 16 Noom's New Outcomes-Based Pricing Model is Poised to Disrupt the Healthcare Market Noom,
Published by
PR Newswire
08 Dec 16 Hanson Research Acquired by Teledyne Instruments Hanson Research Corporation,
Published by
PR Newswire
08 Dec 16 Exact Imaging Receives FDA 510(k) Clearance for Its ExactVu™ Micro-Ultrasound System Exact Imaging,
Published by
PR Newswire
08 Dec 16 HedgePath Pharmaceuticals Announces Uplisting to OTCQX HedgePath Pharmaceuticals, Inc.,
Published by
PR Newswire
08 Dec 16 Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference Edwards Lifesciences Corporation,
Published by
PR Newswire
08 Dec 16 Provectus Biopharmaceuticals Announces Agreement with POETIC (Pediatric Oncology Experimental Therapeutics Investigators Consortium) to Study Potential of PV-10 for Pediatric Cancer Provectus Biopharmaceuticals, Inc.,
Published by
Business Wire
08 Dec 16 PellePharm Launches with Financing from BridgeBio Pharma to Develop Topical Therapy for Basal Cell Carcinomas and Gorlin Syndrome PellePharm,
Published by
Business Wire
08 Dec 16 Nordic Nanovector: Re Mandatory Notification of Trade - Primary Insider Nordic Nanovector,
Published by
Business Wire
08 Dec 16 Further research confirms that Verseon’s new class of anticoagulants reduce bleeding risk compared to NOACs by preserving platelet function Verseon,
Published by
Business Wire
08 Dec 16 Daiichi Sankyo Announces Initiation of Real-World Study in LIXIANA®? (edoxaban) Patients Undergoing Diagnostic and Therapeutic Procedures in NVAF and VTE Daiichi Sankyo Company, Limited,
Published by
PR Newswire
08 Dec 16 Daiichi Sankyo Announces Initiation of Real-World Study in LIXIANA®? (edoxaban) Patients Undergoing Diagnostic and Therapeutic Procedures in NVAF and VTE. Daiichi Sankyo Company, Limited,
Published by
PR Newswire
08 Dec 16 Citius Moves Forward with Mino-Lok™ Phase 3 Trial Citius Pharmaceuticals, Inc.,
Published by
PR Newswire
08 Dec 16 Soligenix Announces Positive Long-Term Follow-up Results from its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients Soligenix, Inc.,
Published by
PR Newswire
08 Dec 16 Soligenix Announces Investor Webcast Event: Origins of Innate Defense Regulators and Review of the SGX942 Phase 2 Study Results in Oral Mucositis Soligenix, Inc.,
Published by
PR Newswire
08 Dec 16 Albumedix and NYU School of Medicine to Investigate Targeting Novel Cellular Pathways in Oncology Albumedix,
Published by
Discovery PR
08 Dec 16 Pihlajalinna Plc: Managers' transactions Pihlajalinna Oyj,
Published by
GlobeNewswire
08 Dec 16 Can genetic testing determine antimicrobial susceptibility? EUCAST experts say not yet… ESCMID,
Published by
De Facto Communications
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.